---
title: "SONOSCAPE responds to U.S. tariff adjustments: The company's revenue from the U.S. market accounts for less than 2%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235215748.md"
description: "According to information from SONOSCAPE, the United States' imposition of \"reciprocal tariffs\" has little impact on the company, as revenue from the U.S. market accounts for less than 2% of the company's total revenue, and U.S. agents have already made appropriate stock preparations in advance. The company has been expanding overseas for many years and has a well-established operation. In recent years, it has strengthened its localization efforts and gradually established subsidiaries overseas. In the future, the company will further increase its investment in overseas markets, focusing on expansion in regions such as Europe, Russia, India, and Latin America"
datetime: "2025-04-09T11:38:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235215748.md)
  - [en](https://longbridge.com/en/news/235215748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235215748.md)
generator: "portal-rs"
---

# SONOSCAPE responds to U.S. tariff adjustments: The company's revenue from the U.S. market accounts for less than 2%

According to reports from SONOSCAPE, the impact of the United States imposing "reciprocal tariffs" on the company is minimal, as revenue from the U.S. market accounts for less than 2% of the company's total revenue, and U.S. agents have already made appropriate stock preparations in advance. The company has been expanding overseas for many years and has a well-established operation. In recent years, it has strengthened its localization efforts and gradually established subsidiaries abroad. In the future, the company will further increase its investment in overseas markets, focusing on expansion in regions such as Europe, Russia, India, and Latin America

### Related Stocks

- [300633.CN](https://longbridge.com/en/quote/300633.CN.md)

## Related News & Research

- [Lifecare Boosts Majority Stake in Ocean TuniCell with New Share Issue](https://longbridge.com/en/news/298763508.md)
- [REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/298737782.md)
- [Active Biotech AB (publ) (STO:ACTI): Is Breakeven Near?](https://longbridge.com/en/news/298678959.md)
- [Sleep Cycle targets EU Class I CE mark for sleep apnea risk detection launch in early 2027](https://longbridge.com/en/news/298724641.md)
- [Eurofins Scientific reports 176 million shares, 362,395,012 voting rights outstanding as of Aug. 31, 2026](https://longbridge.com/en/news/298619523.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**